As the 2018 International AIDS Conference kicks off in Amsterdam (23-27 July), Gottfried Hirnschall, Director of the HIV/AIDS Department and the Global Hepatitis Programme of the World Health Organization, discussed in a wide-ranging interview with John Zarocostas for Health Policy Watch the advances, setbacks, and challenges ahead in the global fight against the HIV/AIDS epidemic. On 18 July, a new report by UNAIDS warned that new infections are rising in around 50 countries, and that AIDS-related deaths are not falling fast enough and flat resources are threatening success. Dr Hirnschall leads the WHO's work in development and implementation of cutting-edge normative policies and guidance, and of technical support to countries to scale up national responses to HIV and hepatitis. He also oversees the Global Hepatitis Programme, which coordinates the organisation’s response to viral hepatitis. Hirnschall holds an MD from the University of Vienna, Austria, and an MPH from the Johns Hopkins Bloomberg School of Public Health. Continue reading ->
Three international organisations playing a key role in the global effort to address rising human resistance to known antibiotics today announced a report on efforts at the national level worldwide, including with animal health, recognised as one of the key sources of resistance. In sum: progress is being made, but "serious gaps remain." Continue reading ->
Or they should be. That’s the conclusion of a recent study published in the medical journal Vaccine. The study focused on political views of parents in the state of California, who had chosen not to vaccinate their nursery-school aged children. And it tracked the number of parents who had filed personal belief exemptions (PBEs), applications for permission to avoid vaccinations over a 5-year period to 2015. A disproportionate number of parents filing such forms were from Republican or conservative neighbourhoods, according to researcher Kevin A Estep, from the health administration and policy program at the university. Continue reading ->
Basic research in health is often conducted by public universities or institutions, and public health activists have underlined the view that because research is funded by public money, medicines should not be so highly priced. A new study by an independent economic research institute shows that the pharmaceutical industry is a substantial partner in research activities and its investment in basic research is growing. The study, however, falls short of providing answers to key questions such as what is included in research and development figures, or what kind of basic research is conducted. Continue reading ->
The United Nations General Assembly held a hearing on 5 July to engage civil society in the preparatory process toward the third High-Level Meeting on Non-Communicable Diseases to be held at the UN in New York on 27 September. Continue reading ->
Early results of a biopharmaceutical companies-based initiative to encourage access to treatment in developing countries shows a focus on cancer, diabetes, and cardiovascular disease, through 62 programmes. The report, conducted by an independent observatory, provides key findings on several areas, including local priorities, and social inequity. Continue reading ->
Accountability and prevention and response to harassment, including sexual harassment, bullying and abuse of power, are high on the minds of delegates attending a three-day meeting of the ruling body of UNAIDS this week in Geneva. Continue reading ->
The 2018 World Food Prize was awarded today to David Nabarro and Lawrence Haddad, for their work reducing maternal and child malnutrition. According to the World Food Prize press release, their efforts contributed toward “reducing the world’s number of stunted children by 10 million between 2012 and 2017.” Continue reading ->
The UN Human Rights Council session last week saw mental health placed at the forefront with the report of the Special Rapporteur on the Right to Health. Continue reading ->
Dr Carlos Maria Correa, an Argentinian economist and lawyer, is globally renowned for his expertise on international trade, intellectual property, health, technology transfer, investment policy and especially their impact on developing countries. He has authored several books and academic articles and been a visiting professor at several universities. Additionally, he has consulted with many United Nations agencies, the World Bank, and other regional and international organisations and has advised several governments on intellectual property, innovation policy and public health. Correa was a member of the UK Commission on Intellectual Property, of the Commission on Intellectual Property, Innovation and Public Health established by the World Health Assembly and of the FAO Panel of Eminent Experts on Ethics in Food and Agriculture. Currently, he is the Director of the Centre for Interdisciplinary Studies on Industrial Property and Economics Law, at the University of Buenos Aires. He takes over as the Executive Director of the Secretariat of the Geneva-based South Centre from 1 July 2018. Correa recently engaged in an interview with Patralekha Chatterjee for Intellectual Property Watch. [Note: this interview is number two of two. The first, with Dr Othoman Mellouk, is available here.] Continue reading ->